RA Capital Management Opposes BioCryst Pharmaceuticals' Proposed Merger with Idera Pharmaceuticals
Go back to RA Capital Management Opposes BioCryst Pharmaceuticals' Proposed Merger with Idera Pharmaceuticals| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.55 | 52 Week High | $10.98 | |||
| Open | $9.55 | 52 Week Low | $1.63 | |||
| Day High | $9.55 | P/E | N/A | |||
| Day Low | $9.55 | EPS | $-0.68 | |||
| Volume | 60 | |||||
| Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) | Delayed: 0.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $4.42 | |||
| Open | $152.77 | 52 Week Low | $1.19 | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.43 | EPS | $-0.64 | |||
| Volume | 14,006 | |||||
